Diverse mechanisms of antiepileptic drugs in the development pipeline
about
Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activityModifications of antiepileptic drugs for improved tolerability and efficacyNew molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channelsMolecular targets for antiepileptic drug developmentNav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodentsMechanisms of Action of Antiseizure Drugs and the Ketogenic DietAnticonvulsant Effects of Fractions Isolated from Dinoponera quadriceps (Kempt) Ant Venom (Formicidae: Ponerinae)The safety and tolerability of newer antiepileptic drugs in children and adolescents.Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112)Probable levetiracetam-related serum alkaline phosphatase elevation.KB-R7943 reduces 4-aminopyridine-induced epileptiform activity in adult rats after neuronal damage induced by neonatal monosodium glutamate treatment.17beta-Nitro-5alpha-androstan-3alpha-ol and its 3beta-methyl derivative: neurosteroid analogs with potent anticonvulsant and anxiolytic activities.The novel antiepileptic drug carisbamate (RWJ 333369) is effective in inhibiting spontaneous recurrent seizure discharges and blocking sustained repetitive firing in cultured hippocampal neurons.Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.Acute mania associated with levetiracetam treatment.Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activityLithium acts as a potentiator of AMPAR currents in hippocampal CA1 cells by selectively increasing channel open probability.Metabotropic glutamate receptors in the thalamocortical network: strategic targets for the treatment of absence epilepsy.Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations.Sodium valproate induced gingival enlargement in 22 months old child.Ion channel pharmacology.Emerging drugs for epilepsy.Antiepileptic and antiepileptogenic performance of carisbamate after head injury in the rat: blind and randomized studies.Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.New Horizons in the development of antiepileptic drugs: Innovative strategies.Novel glutamatergic agents for major depressive disorder and bipolar disorder.A comparative bioavailability study of two formulations of pregabalin in healthy Chilean volunteers.Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets.Currently available antiepileptic drugs.Valproic Acid: second generation.Challenges in the design and conduct of therapeutic trials in channel disorders.Ketogenic diets and thermal pain: dissociation of hypoalgesia, elevated ketones, and lowered glucose in ratsVascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance.Carisbamate prevents the development and expression of spontaneous recurrent epileptiform discharges and is neuroprotective in cultured hippocampal neuronsAntisense reduction of tau in adult mice protects against seizuresIonotropic glutamate receptors & CNS disorders.Computer modelling of epilepsyNeuronal Injury, Gliosis, and Glial Proliferation in Two Models of Temporal Lobe Epilepsy.Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro.Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)
P2860
Q24612607-C66290F2-A654-48AB-9BB8-A1F30ABA7E7AQ24651951-21F5E243-10DD-45CE-A173-EFEBD2A33EC1Q24654230-0AFCEACD-071E-4745-BAB5-AC17B8FCC973Q24683346-34B6159D-F841-417E-BF16-EC644398F26BQ28235994-2DAF2221-A50E-4A3E-A2B2-30208AAD717BQ28272457-C9C737CD-150B-4870-8ED7-D67429D9D1C2Q28816931-7ACFE38F-5474-45FE-B07A-B72FAB42BCA5Q30454834-3601AAD6-9ACE-49E6-B1E8-5DF52741BC84Q30577314-F8378247-D3BD-4957-9045-03F000479CE9Q31096235-0CEACD08-BEDA-42F3-A976-908C9778D859Q33651868-58174FDE-B9E9-41F3-90A7-AF8443A1D22CQ33693153-78EE9285-4B9F-47EE-AC87-92BC90C93119Q33740459-F83849E7-85D0-4DA0-8926-CDEBD16F8D88Q33833726-BB781E3E-C7F8-465D-A72C-3AEDA1CECA39Q33887278-55CE481F-A07A-41D1-85DA-F29BAD9D69D1Q34101256-4125960A-3937-4032-AA73-BD0425DB33B3Q34135203-EE655036-18C2-4836-B0E3-2837332AEA2BQ34184809-D47B3D5A-93C1-403E-A898-82A5FD11C4E3Q34186198-FCECFE0E-3610-4314-84CC-DEF8D7B10A31Q34553382-C34055ED-910C-4173-890C-86255C1C17D1Q34613758-214D2F48-55E4-48F6-9D19-52DFB60D7114Q34688725-C28563E4-8376-47FB-9E9C-26C6F0B1D809Q34702245-FEC71E9F-E3ED-4B16-A3EE-EC4A880424B3Q34766451-05059264-0874-47B8-BA97-2CB9722580D6Q35046545-508208E3-60D0-4CF3-B16E-B62BDA7814D6Q35661119-6688DAE6-5837-4ED0-B844-E0E591C96CC3Q36443685-C4149D70-4BC1-41EE-A05E-19426C92DE37Q36576250-13060FE3-8BCC-4AAF-A391-9CDF8F9879F2Q36697463-A64A97B2-70DE-42CE-990E-77B64BEFA1CBQ36697494-977ED780-B09B-488C-AFBB-041F54F821F6Q36774698-E9B205E5-CD10-4095-BD04-01DDEE4BF61CQ36816412-3B8125EC-0AC3-4B34-B7DB-4D263C282067Q37001792-BB0130C0-9E51-41BF-AB7E-1296E7ECFC65Q37045473-CC4DFBA8-6F54-4EE0-AE5E-DBFE14908F64Q37058143-E53D11F1-4FDB-4D08-AFBF-55E11913DEF6Q37143580-92B6D439-31BC-40E4-BCA0-1BA87DFE6BB4Q37204997-C9699461-5043-441F-9439-40E8D0C65F1BQ37228255-11C5FA14-A1F0-44E0-A468-B515207A8EE6Q37230762-42DEECBA-0BC6-4FC0-A297-69ADBC0D4939Q37242260-2B69D5EF-B555-438D-9BBC-5572B62B6B3A
P2860
Diverse mechanisms of antiepileptic drugs in the development pipeline
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Diverse mechanisms of antiepileptic drugs in the development pipeline
@ast
Diverse mechanisms of antiepileptic drugs in the development pipeline
@en
Diverse mechanisms of antiepileptic drugs in the development pipeline
@nl
type
label
Diverse mechanisms of antiepileptic drugs in the development pipeline
@ast
Diverse mechanisms of antiepileptic drugs in the development pipeline
@en
Diverse mechanisms of antiepileptic drugs in the development pipeline
@nl
prefLabel
Diverse mechanisms of antiepileptic drugs in the development pipeline
@ast
Diverse mechanisms of antiepileptic drugs in the development pipeline
@en
Diverse mechanisms of antiepileptic drugs in the development pipeline
@nl
P2860
P3181
P1433
P1476
Diverse mechanisms of antiepileptic drugs in the development pipeline
@en
P2093
Michael A Rogawski
P2860
P304
P3181
P356
10.1016/J.EPLEPSYRES.2006.02.004
P407
P577
2006-04-18T00:00:00Z